[{"indications": "Indications\u00a0see under Dose and under preparations", "name": "URSODEOXYCHOLIC ACID", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.9 Drugs affecting intestinal secretions", "1.9.1 Drugs affecting biliary composition and flow", "URSODEOXYCHOLIC ACID"], "cautions": "Cautions\u00a0\n(From 1.9.1 Drugs affecting biliary composition and flow: British National Formulary)\nit should be used cautiously in those with liver disease (but see below). Patients should be given dietary advice (including avoidance of excessive cholesterol and calories) and they require radiological monitoring. Long-term prophylaxis may be needed after complete dissolution of the gallstones has been confirmed because they may recur in up to 25% of patients within one year of stopping treatment.; interactions: Appendix 1 (bile acids)", "side-effects": "Side-effects\u00a0diarrhoea; very rarely abdominal\r\npain, gallstone calcification, urticaria; also reported nausea, vomiting, pruritus", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2289.htm", "doses": ["Dissolution of gallstones, 8\u201312\u00a0mg/kg daily as a single\r\ndose at bedtime or in two divided doses, for up to\r\n2 years; treatment is continued for 3\u20134 months after\r\nstones dissolve", "Primary biliary cirrhosis, see under Ursofalk\u00ae"], "pregnancy": "Pregnancy\u00a0no evidence of harm but manufacturer advises avoid"}]